Abstract

Increasing evidence has indicated that plenty of lncRNAs play important roles in many critical biological processes. Developing powerful computational models to construct lncRNA functional similarity network based on heterogeneous biological datasets is one of the most important and popular topics in the fields of both lncRNAs and complex diseases. Functional similarity network consturction could benefit the model development for both lncRNA function inference and lncRNA-disease association identification. However, little effort has been attempted to analysis and calculate lncRNA functional similarity on a large scale. In this study, based on the assumption that functionally similar lncRNAs tend to be associated with similar diseases, we developed two novel lncRNA functional similarity calculation models (LNCSIM). LNCSIM was evaluated by introducing similarity scores into the model of Laplacian Regularized Least Squares for LncRNA–Disease Association (LRLSLDA) for lncRNA-disease association prediction. As a result, new predictive models improved the performance of LRLSLDA in the leave-one-out cross validation of various known lncRNA-disease associations datasets. Furthermore, some of the predictive results for colorectal cancer and lung cancer were verified by independent biological experimental studies. It is anticipated that LNCSIM could be a useful and important biological tool for human disease diagnosis, treatment, and prevention.

Highlights

  • Increasing evidence has indicated that plenty of Long noncoding RNAs (lncRNAs) play important roles in many critical biological processes

  • Considering the important roles of lncRNAs in various biological processes, it is no surprise that mutations and dysregulations of lncRNAs have been linked to the development and progression of a broad range of complex human diseases[8,12,14,15,47,48,49,50], such as breast cancer[51,52,53,54], hepatocellular cancer[55,56,57,58,59,60], prostate cancer[61,62,63,64,65], colon cancer[66], bladder cancer[67], thyroid cancer[68], lung cancer[69,70], ovarian cancer[54], leukemia[71,72], Alzheimer’s diseases[73], diabetes[74,75], and HIV76. lncRNA PCA3 has about 60 times expression levels in prostate tumors compared with normal tissues, PCA3 has been treated as a well-known example of potential cancer diagnostic biomarker[38,47,64]

  • To validate the performance of lncRNA functional similarity calculation models (LNCSIM), we introduced lncRNA functional similarity into the model of Laplacian Regularized Least Squares for LncRNA–Disease Association (LRLSLDA) for lncRNA-disease associations prediction developed in the previous work[78]

Read more

Summary

Introduction

Increasing evidence has indicated that plenty of lncRNAs play important roles in many critical biological processes. To validate the performance of LNCSIM, we introduced lncRNA functional similarity into the model of LRLSLDA for lncRNA-disease associations prediction developed in the previous work[78]. The reliable AUCs of 0.8130 and 0.8198 are obtained in the leave-one-out cross validation (LOOCV) of known experimentally confirmed lncRNA-disease association in the LncRNADisease for two versions of lncRNA similarity scores, increasing AUCs of 0.037 and 0.0438 than previous LRLSLDA, respectively.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.